A 41-year-old man whose systemic lupus erythematosus (SLE) had been successfully treated for 15 months with a daily maintenance dose of 5 mg prednisolone, developed benign intracranial hypertension (BIH) when the steroid was increased to 60 mg daily for recrudescence of SLE symptoms. The BIH remitted when the steroid was discontinued.
Introduction
Relationship of steroids with benign intracranial hypertension (BIH) is well documented. It has been reported to occur either on withdrawal of steroids or change to another preparation (Walker and Adamkiewicz, 1964; Hagberg and Sillanpiai, 1970; Weisberg, 1975) . Development of BIH while on maintenance steroid therapy or increase in its dose is an uncommon phenomenon in adults, although well reported in paediatric populations (Cohn, 1963; Gordon and Kelsey, 1967) . Such a case is now described from an adult who was being treated for systemic lupus erythematosus (SLE).
Case report
A 41-year-old man with SLE had had this condition successfully controlled for 15 months with a daily maintenance dose of 5 mg prednisolone. When he had a recrudescence of symptoms (arthralgia, purpuric spots; strongly positive L.E. cells and antinuclear factor), the daily dose of prednisolone was increased to 60 mg. Within Dandy, 1937) . Johnston and Paterson (1974) suggested the following diagnostic criteria for BIH: the symptoms should be those of raised intracranial pressure alone; the clinical signs should be those of intracranial hypertension; the major investigations, particularly contrast radiology, should be entirely normal apart from non-specific evidence of raised intracranial pressure; there must be a measurable increase in CSF pressure but the fluid must be of normal composition. The present patient fulfils all these 4 criteria.
Two children are reported to have developed BIH while on long maintenance doses of triamcinolone (Cohn, 1963) . Green, Cleveland and Wilkins (1961) reported 4 children, with the congenital adrenogenital syndrome, who were receiving triamcinolone therapy and who developed blurring of the optic discs.
In a review of 28 cases it is observed that the occurrence of BIH is related either to the withdrawal or reduction in dose of a steroid, or to a change to another drug (Walker and Adamkiewicz, 1964) .
In the present case, BIH appeared when the daily dose of prednisolone was increased to 60 mg, and the symptoms and signs regressed gradually when the steroid was tapered. This clearly indicates that the development of BIH was related to the increase in the dose of steroid.
Benign intracranial hypertension has also been reported as a manifestation of SLE (Bettman et al., 1968; Weisberg, 1975 
